David Poplack, M.D.

Contact Information:

6621 Fannin St., MC 3-3320
Houston, TX 77030

Phone: 832-822-4556
Fax: 832-825-4299
[email protected]

Current Positions:

Director, Texas Children's Cancer Center
Elise C. Young Professor of Pediatric Oncology
Head, Hematology-Oncology Section, Department of Pediatrics, Baylor College of Medicine

Education:

M.D., Boston University School of Medicine
Internship, Stanford University Hospital
Residency, Children's Hospital Medical Center, Boston
Fellowship, National Cancer Institute

Board Certifications:

Diplomate, American Board of Pediatrics; Certified Sub-specialty, Board of Pediatrics Hematology/Oncology

Clinical Special Interests:

Chief of Service

Selected Publications:

Pizzo PA, Poplack DG: Principles and Practice of Pediatric Oncology (Fifth edition) Philadelphia, PA: Lippincott Williams & Wilkins, 2005

Blaney SM, Heideman, R., Berg S, Adamson P, Gillespie A, Geyer JR, Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, Poplack DG, Balis FM. Phase I clinical trial of Intrathecal Topetecan in patients with neoplastic meningitis. Journal of Clinical Oncology, 2003, 21: 143-147.

Margolin, JF, and Poplack, DG. Review of article “What is the optimal therapy for childhood AML? Oncology, 2002, 1069-1070

Steuber CP and Poplack DG. Acute Lymphoblastic Leukemia. In Rudolph CD, Rudolph AM, Hostetter MK, Lister G, Siegel NJ (eds). Rudolph’s Pediatrics, 21st Edition. New York. McGraw-Hill Medical Publishing Division, pp. 1594-1600, 2002.

Bomgaars L, Chamberlain MC, Poplack DG and Blaney M. Leptomeningeal metastases. In Levin VA (ed). Cancer in the Nervous System, Second Edition. New York. Oxford University Press, pp. 375-396, 2002.

Poplack DG. Pediatric Oncology. In: Sumner Yaffee, (Ed). Rational Therapeutics for Infants and Children. Institute of Medicine Workshop Summary, Washington, D.C., National Academy Press, 2000.

Balis FM, Blaney SM, McCully CL, Bacher JD, Murphy RF, Poplack DG. Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol 45(3), 259-264, 2000.

Moser AM, Adamson PC, Gillespie AJ, Poplack DG, Balis FM. Intraventricular concentration times time (CxT) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer 85 (2), 511-516, 1999.

Roth JS, McCully CM, Balis FM, Poplack DG, Kelley JA. 2’-ß-fluoro-2’, 3’-dideoxyadenosine, lodenosine, in Rhesus monkeys: Plasma and cerebrospinal fluid pharmacokinetics and urinary disposition. Drug Metabolism and Disposition, 29 (10), 1128-1132, 1999.

Serabe BM, Murry DJ, Dauser R, Nuchtern J, Durfee J, McGuffey L, Aleksic A, Berg S, Poplack DG, Blaney SM. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates. Cancer, Chemother Pharmacol, 43(5):415-418, 1999.

Berg SL, Reid J, Godwin K, Murry DJ, Poplack DG, Balis F, Ames MM. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model. Journal of Pediatric Hematology/Oncology, 21 (1):26-30, 1999.



Page modified on April 13, 2022